← Open Payments lookup

NICKOLAS CULPEPPER: Open Payments

NPI 1184069544 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,545 in 133 payments from 16 companies in 2025. Trend: 2023 $837 · 2024 $1,292 · 2025 $2,545

Food & beverage: $2,545
CompanyPaymentsAmount
ABBVIE INC.21$410
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$342
Vanda Pharmaceuticals Inc.18$265
Tris Pharma Inc8$241
Otsuka America Pharmaceutical, Inc.12$215
Teva Pharmaceuticals USA, Inc.7$157
Alkermes, Inc.6$152
Janssen Pharmaceuticals, Inc7$141
Collegium Pharmaceutical, Inc.11$139
E.R. Squibb & Sons, L.L.C.5$134

Products named: VRAYLAR, CAPLYTA, FANAPT, AUSTEDO XR, ARISTADA, Jornay PM, COBENFY, REXULTI.

Industry payments across NV — which companies pay providers there.